Table of Contents

2018-2023 Global Levodopa Consumption Market Report

1 Scope of the Report

• 1.1 Market Introduction
• 1.2 Research Objectives
• 1.3 Years Considered
• 1.4 Market Research Methodology
• 1.5 Economic Indicators
• 1.6 Currency Considered

2 Executive Summary

• 2.1 World Market Overview
  • 2.1.1 Global Levodopa Consumption 2013-2023
  • 2.1.2 Levodopa Consumption CAGR by Region
• 2.2 Levodopa Segment by Type
  • 2.2.1 0.98
  • 2.2.2 0.99
  • 2.2.3 Others
• 2.3 Levodopa Consumption by Type
  • 2.3.1 Global Levodopa Consumption Market Share by Type (2013-2018)
  • 2.3.2 Global Levodopa Revenue and Market Share by Type (2013-2018)
  • 2.3.3 Global Levodopa Sale Price by Type (2013-2018)
• 2.4 Levodopa Segment by Application
  • 2.4.1 Pharmaceuticals Industry
  • 2.4.2 Dietary Supplements
• 2.5 Levodopa Consumption by Application
  • 2.5.1 Global Levodopa Consumption Market Share by Application (2013-2018)
  • 2.5.2 Global Levodopa Value and Market Share by Application (2013-2018)
  • 2.5.3 Global Levodopa Sale Price by Application (2013-2018)

3 Global Levodopa by Players

• 3.1 Global Levodopa Sales Market Share by Players
  • 3.1.1 Global Levodopa Sales by Players (2016-2018)
  • 3.1.2 Global Levodopa Sales Market Share by Players (2016-2018)
• 3.2 Global Levodopa Revenue Market Share by Players
  • 3.2.1 Global Levodopa Revenue by Players (2016-2018)
  • 3.2.2 Global Levodopa Revenue Market Share by Players (2016-2018)
• 3.3 Global Levodopa Sale Price by Players
• 3.4 Global Levodopa Manufacturing Base Distribution, Sales Area, Product Types by Players
  • 3.4.1 Global Levodopa Manufacturing Base Distribution and Sales Area by Players
  • 3.4.2 Players Levodopa Products Offered
• 3.5 Market Concentration Rate Analysis
  • 3.5.1 Competition Landscape Analysis
  • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
• 3.6 New Products and Potential Entrants
• 3.7 Mergers & Acquisitions, Expansion

4 Levodopa by Regions

• 4.1 Levodopa by Regions
  • 4.1.1 Global Levodopa Consumption by Regions
  • 4.1.2 Global Levodopa Value by Regions
• 4.2 Americas Levodopa Consumption Growth
• 4.3 APAC Levodopa Consumption Growth
• 4.4 Europe Levodopa Consumption Growth
• 4.5 Middle East & Africa Levodopa Consumption Growth

5 Americas

• 5.1 Americas Levodopa Consumption by Countries
  • 5.1.1 Americas Levodopa Consumption by Countries (2013-2018)
  • 5.1.2 Americas Levodopa Value by Countries (2013-2018)
• 5.2 Americas Levodopa Consumption by Type
• 5.3 Americas Levodopa Consumption by Application
• 5.4 United States
• 5.5 Canada
• 5.6 Mexico
• 5.7 Key Economic Indicators of Few Americas Countries

6 APAC

• 6.1 APAC Levodopa Consumption by Countries
  • 6.1.1 APAC Levodopa Consumption by Countries (2013-2018)
  • 6.1.2 APAC Levodopa Value by Countries (2013-2018)
• 6.2 APAC Levodopa Consumption by Type
• 6.3 APAC Levodopa Consumption by Application
• 6.4 China
• 6.5 Japan
• 6.6 Korea
• 6.7 Southeast Asia
• 6.8 India
• 6.9 Australia
• 6.10 Key Economic Indicators of Few APAC Countries

7 Europe

• 7.1 Europe Levodopa by Countries
  • 7.1.1 Europe Levodopa Consumption by Countries (2013-2018)
  • 7.1.2 Europe Levodopa Value by Countries (2013-2018)
• 7.2 Europe Levodopa Consumption by Type
• 7.3 Europe Levodopa Consumption by Application
• 7.4 Germany
• 7.5 France
• 7.6 UK
• 7.7 Italy
• 7.8 Russia
• 7.9 Spain
• 7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

• 8.1 Middle East & Africa Levodopa by Countries
  • 8.1.1 Middle East & Africa Levodopa Consumption by Countries (2013-2018)
  • 8.1.2 Middle East & Africa Levodopa Value by Countries (2013-2018)
• 8.2 Middle East & Africa Levodopa Consumption by Type
• 8.3 Middle East & Africa Levodopa Consumption by Application
• 8.4 Egypt
• 8.5 South Africa
• 8.6 Israel
• 8.7 Turkey
• 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

• 9.1 Market Drivers and Impact
  • 9.1.1 Growing Demand from Key Regions
  • 9.1.2 Growing Demand from Key Applications and Potential Industries
• 9.2 Market Challenges and Impact
• 9.3 Market Trends

10 Marketing, Distributors and Customer

• 10.1 Sales Channel
  • 10.1.1 Direct Marketing
  • 10.1.2 Indirect Marketing
• 10.2 Levodopa Distributors
• 10.3 Levodopa Customer

11 Global Levodopa Market Forecast

• 11.1 Global Levodopa Consumption Forecast (2018-2023)
• 11.2 Global Levodopa Forecast by Regions
  • 11.2.1 Global Levodopa Forecast by Regions (2018-2023)
  • 11.2.2 Global Levodopa Value Forecast by Regions (2018-2023)
  • 11.2.3 Americas Consumption Forecast
  • 11.2.4 APAC Consumption Forecast
  • 11.2.5 Europe Consumption Forecast
  • 11.2.6 Middle East & Africa Consumption Forecast
• 11.3 Americas Forecast by Countries
  • 11.3.1 United States Market Forecast
  • 11.3.2 Canada Market Forecast
  • 11.3.3 Mexico Market Forecast
  • 11.3.4 Brazil Market Forecast
• 11.4 APAC Forecast by Countries
  • 11.4.1 China Market Forecast
  • 11.4.2 Japan Market Forecast
  • 11.4.3 Korea Market Forecast
  • 11.4.4 Southeast Asia Market Forecast
  • 11.4.5 India Market Forecast
  • 11.4.6 Australia Market Forecast
• 11.5 Europe Forecast by Countries
  • 11.5.1 Germany Market Forecast
  • 11.5.2 France Market Forecast
  • 11.5.3 UK Market Forecast
  • 11.5.4 Italy Market Forecast
  • 11.5.5 Russia Market Forecast
  • 11.5.6 Spain Market Forecast
• 11.6 Middle East & Africa Forecast by Countries
  • 11.6.1 Egypt Market Forecast
  • 11.6.2 South Africa Market Forecast
  • 11.6.3 Israel Market Forecast
  • 11.6.4 Turkey Market Forecast
  • 11.6.5 GCC Countries Market Forecast
• 11.7 Global Levodopa Forecast by Type
• 11.8 Global Levodopa Forecast by Application

12 Key Players Analysis

• 12.1 Xi'an Lyphar Biotech
  • 12.1.1 Company Details
  • 12.1.2 Levodopa Product Offered
  • 12.1.3 Xi'an Lyphar Biotech Levodopa Sales, Revenue, Price and Gross Margin (2016-2018)
  • 12.1.4 Main Business Overview
  • 12.1.5 Xi'an Lyphar Biotech News
• 12.2 Hindustan Herbals
  • 12.2.1 Company Details
  • 12.2.2 Levodopa Product Offered
  • 12.2.3 Hindustan Herbals Levodopa Sales, Revenue, Price and Gross Margin (2016-2018)
  • 12.2.4 Main Business Overview
  • 12.2.5 Hindustan Herbals News
• 12.3 Xi'an ZB Biotech
  • 12.3.1 Company Details
  • 12.3.2 Levodopa Product Offered
  • 12.3.3 Xi'an ZB Biotech Levodopa Sales, Revenue, Price and Gross Margin (2016-2018)
  • 12.3.4 Main Business Overview
  • 12.3.5 Xi'an ZB Biotech News
• 12.4 Xi'an Arisun ChemPharm
  • 12.4.1 Company Details
  • 12.4.2 Levodopa Product Offered
  • 12.4.3 Xi'an Arisun ChemPharm Levodopa Sales, Revenue, Price and Gross Margin (2016-2018)
  • 12.4.4 Main Business Overview
  • 12.4.5 Xi'an Arisun ChemPharm News
• 12.5 Hunan Nutramax
  • 12.5.1 Company Details
  • 12.5.2 Levodopa Product Offered
  • 12.5.3 Hunan Nutramax Levodopa Sales, Revenue, Price and Gross Margin (2016-2018)
  • 12.5.4 Main Business Overview
  • 12.5.5 Hunan Nutramax News

...

13 Research Findings and Conclusion

Levodopa is a naturally occurring dietary supplement and psychoactive drug found in certain kinds of food and herbs, and is synthesized from the amino acid L-tyrosine in the mammalian body and brain.
Aside from its natural and essential biological role, L-DOPA is also used in the clinical treatment of Parkinson's disease and dopamine-responsive dystonia. When used in a pharmaceutical context, the INN designation 'levodopa' is normally used.

According to this study, over the next five years the Levodopa market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2017. In particular, this report presents the global market share (sales and revenue) of key companies in Levodopa business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Levodopa market by product type, application, key manufacturers and key regions and countries.

This study considers the Levodopa value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2013 to 2018, in Section 2.3; and forecast to 2024 in section 11.7.
0.98
0.99
Others
Segmentation by application: breakdown data from 2013 to 2018, in Section 2.4; and forecast to 2024 in section 11.8.
Pharmaceuticals Industry
Dietary Supplements

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Xi'an Lyphar Biotech
Hindustan Herbals
Xi'an ZB Biotech
Xi'an Arisun ChemPharm
Hunan Nutramax
...

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Levodopa consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2024.
To understand the structure of Levodopa market by identifying its various subsegments.
Focuses on the key global Levodopa manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Levodopa with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Levodopa submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.